In accordance with Regulation 30, read with Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and in continuation of the Intimation ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Shiv Texchem Ltd shared its investor presentation ahead of an analyst/institutional investor meet, outlining its chemical import and distribution business model. The company imports and distributes hydrocarbon-based chemicals to industries like paints, agro-chemicals, pharmaceuticals, and printing inks, with storage at 5 major ports. FY25 total income stood at Rs 2,205 Cr (37% revenue CAGR over FY22-25), while H1FY26 showed strong momentum with total income of Rs 1,506 Cr (up 46% YoY) and PAT more than doubling to Rs 43 Cr. Management guided for FY26E revenue of Rs 3,100 Cr and FY27E revenue of Rs 4,200 Cr (38% CAGR), with EBITDA projected to grow from Rs 89 Cr in FY25 to Rs 175 Cr by FY27E. The company is pivoting toward higher-margin specialty products like Mixed Heptane (25% gross margin) and disclosed recent orders from BASF India (Rs 15 Cr), GNFC (Rs 11 Cr), and others.
The filing reveals strong growth momentum and credible multi-year guidance that could boost investor confidence. However, the stock trades at a small-cap level with thin 4% EBITDA margins and elevated working capital, so execution against these aggressive targets will be closely watched. No unpublished price-sensitive information was shared, so this is largely a restatement of known strategy with refreshed numbers.